Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₩ 0
Key Takeaways
Risk factor
Moderate default risk
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Green Cross Cell Corporation develops, manufactures, and sells anti-cancer immune cell therapy for liver cancer in South Korea and internationally. It also offers cord blood storage and immune cell bank services. The company was founded in 1992 and is headquartered in Yongin, South Korea.
Buy
Sell